Toyonaka, Japan

Mari Yuasa


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Mari Yuasa

Introduction

Mari Yuasa, an innovative inventor based in Toyonaka, Japan, has made significant contributions to the field of pharmaceuticals, particularly through her work on cephem compounds. With a focus on antibiotic development, Yuasa's inventive spirit has led her to secure two patents that showcase her expertise and dedication in this area.

Latest Patents

Yuasa's latest patents revolve around a 3-[(E)-1-propenyl]cephem compound, which serves as an important intermediate for producing cephem antibiotics. This synthesis process involves isomerizing the corresponding 3-[(Z)-1-propenyl]cephem compound in an inert organic solvent, utilizing the presence of an aromatic thiol. The compound is characterized by a complex formula that includes variables such as R, X, and protective groups that play crucial roles in its functionality and application. Notably, a compound with chlorine can be converted to a 3-[(E)-3-ammonio-1-propenyl]cephem derivative using a tertiary amine.

Career Highlights

Throughout her career, Mari Yuasa has made a notable impact in her role at Sumitomo Chemical Company, Limited. Her innovative approaches and groundbreaking research have not only solidified her reputation as a leader in pharmaceutical inventions but have also contributed to advancements in medical treatments and drug development.

Collaborations

Yuasa has collaborated with esteemed colleagues, including Kazuyuki Yamagata and Hirokazu Murata. These partnerships have fostered an environment of creativity and innovation, enabling groundbreaking discoveries in her field and further enhancing the effectiveness of cephem antibiotics.

Conclusion

In summary, Mari Yuasa stands out as a talented inventor whose work in developing cephem compounds highlights her commitment to pharmaceutical advancements. Her patents not only reflect her innovative thinking but also demonstrate her contribution to enhancing medical treatments. As she continues her work with Sumitomo Chemical Company, Limited, the potential for future discoveries and innovations in antibiotics looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…